Atara Biotherapeutics

Atara engineers T-cells into off-the-shelf cancer killers—allogeneic warriors that attack tumors in any patient. Like bacteriophages reprogrammed to hunt specific bacterial strains, these cell therapies target disease with evolved precision but manufactured speed.